Accelerating Early Phase Biologics From The Clinic To Commercialization

Early-phase biologics programs face a unique set of challenges—from navigating clinical trial design to preparing for scalable manufacturing and regulatory compliance. Success depends on more than scientific innovation; it requires strategic foresight across development, operations, and commercialization.

This webinar explores how integrated planning can streamline the transition from first-in-human studies to commercial readiness. Experts discuss how early decisions around formulation, analytical development, and manufacturing strategy can significantly impact timelines and long-term viability. Topics include aligning CMC activities with clinical milestones, anticipating regulatory expectations, and building flexibility into development plans to accommodate future scale-up.

For emerging biotechs and program leads, the insights shared offer a practical roadmap for reducing risk and maximizing efficiency. Whether you're preparing for IND submission or scaling up for late-phase trials, this session highlights the key considerations that can make or break a biologics program.

Watch the full webinar to learn how to build a development strategy that supports speed, quality, and long-term success.